What is rare disease CDG?
What is rare disease CDG?
Congenital disorders of glycosylation (CDG) are a large group of rare genetic disorders that affect the addition of sugar building blocks, called glycans, to proteins in cells throughout the body. The addition of glycans to proteins is critical to the healthy function of cells.
What is CDG life expectancy?
Treatment and prognosis. PMM2-CDG can be lethal in 20% of patients in the first 4 years of life. Individuals, who survive to childhood have a good life expectancy. The oldest PMM2-CDG patient is in her late 40s.
What is CDG test?
This testing is used to screen patients for suspected congenital disorders of glycosylation (N- and O-glycosylation defects as well as glycan structure analysis). Congenital disorders of glycosylation (CDG) encompass over 150 genetic conditions spanning a broad clinical spectrum.
What is CDG type 1p?
A form of congenital disorders of N-linked glycosylation with characteristics of facial dysmorphism (microcephaly, high forehead, low posterior hairline, strabismus), hypotonia, failure to thrive, intractable seizures, developmental delay, persistent vomiting and gastric bleeding.
What causes CDG disease?
As discussed above, CDG are caused by a deficiency or lack of specific enzymes or other proteins involved in the formation of sugar trees (glycans) and their binding to other proteins or lipids (glycosylation). Glycosylation is an extensive and complex process that modifies 1000’s of proteins.
What is glycoprotein syndrome?
A congenital disorder of glycosylation (previously called carbohydrate-deficient glycoprotein syndrome) is one of several rare inborn errors of metabolism in which glycosylation of a variety of tissue proteins and/or lipids is deficient or defective.
What means glycosylation?
Glycosylation is the attachment of carbohydrates to the backbone of a protein through an enzymatic reaction. A protein that is glycosylated is known as a glycoprotein. The two most common types of protein glycosylation are known as N-glycosylation and O-glycosylation.
How is CDG treated?
Individuals with PGM1-CDG can be treated with D-galactose supplementation, which is usually well tolerated and associated with decreased bleeding, improvement of laboratory markers and increased quality of life in some patients. Larger trials are underway.
What is Fabry disease?
Collapse Section. Fabry disease is an inherited disorder that results from the buildup of a particular type of fat, called globotriaosylceramide, in the body’s cells. Beginning in childhood, this buildup causes signs and symptoms that affect many parts of the body.
What is Jaeken syndrome?
Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken syndrome) is the prototype of a class of genetic multisystem disorders characterized by defective glycosylation of glycoconjugates. It is mostly a severe disorder which presents neonatally.
What is glycoprotein deficiency?
Glycoprotein VI deficiency is a bleeding disorder associated with a decreased ability to form blood clots. Normally, blood clots protect the body after an injury by sealing off damaged blood vessels and preventing further blood loss.
What happens during glycosylation?
Glycosylation (see also chemical glycosylation) is the reaction in which a carbohydrate (or ‘glycan’), i.e. a glycosyl donor, is attached to a hydroxyl or other functional group of another molecule (a glycosyl acceptor) in order to form a glycoconjugate.
